STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.